Plaintiffs oppose immediate appeal in US Xyrem antitrust case
MLex Summary: Jazz Pharmaceuticals and Hikma should not be allowed to immediately appeal an order regarding the amendment of a class in a US antitrust case accusing them of delaying a...To view the full article, register now.
Already a subscriber? Click here to view full article